Todos Medical Ltd. (TOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Nov 4, 2025
Todos Medical Revenue
Todos Medical had revenue of $1.91M in the quarter ending September 30, 2022, with 89.50% growth. This brings the company's revenue in the last twelve months to $10.75M, down -7.84% year-over-year. In the year 2021, Todos Medical had annual revenue of $12.23M with 134.88% growth.
Revenue (ttm)
10.75M
Revenue Growth
-7.84%
P/S Ratio
0.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
332.40K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 12.23M | 7.02M | 134.88% |
| Dec 31, 2020 | 5.21M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| China New Energy Group Co. | 12.51M |
| Northwest Biotherapeutics | 1.09M |
Todos Medical News
- 2 years ago - Todos Medical Announces Insolvency Proceedings in Israel - GlobeNewsWire
- 2 years ago - Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic - GlobeNewsWire
- 2 years ago - Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients - GlobeNewsWire
- 2 years ago - Todos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen Diagnostics - GlobeNewsWire
- 2 years ago - Todos Medical Begins Trading on the OTC Pink Marketplace - GlobeNewsWire
- 2 years ago - Todos Medical Supports Long COVID Awareness Day - GlobeNewsWire
- 2 years ago - Todos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note Holders - GlobeNewsWire
- 2 years ago - Todos Medical Provides Corporate Update - GlobeNewsWire